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Abstract
AIM: To investigate the incidence of non-small-bowel 
abnormalities in patients referred for small bowel cap-
sule endoscopy, this single center study was performed. 
METHODS: Small bowel capsule endoscopy is an ac-
cepted technique to investigate obscure gastrointesti-
nal bleeding. This is defined as bleeding from the di-
gestive tract that persists or recurs without an obvious 
etiology after a normal gastroduodenoscopy and colo-
noscopy. Nevertheless, capsule endoscopy sometimes 
reveals findings outside the small bowel, i.e. , within 
reach of conventional endoscopes. In this retrospective 
single center study, 595 patients undergoing capsule 
endoscopy between 2003 and 2009 were studied. The 
incidence of non-small bowel abnormalities was de-
fined as visible abnormalities detected by capsule en-
doscopy that are located within reach of conventional 
endoscopes. 
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trointestinal bleeding or for suspected Crohn’s disease, 
abnormalities were found in 306 (51.4%). Of these 306 
patients, 85 (27.7%) had abnormalities within reach of 
conventional endoscopes; 63 had abnormalities appar-
ently overlooked at previous conventional endoscopies, 
10 patients had not undergone upper and lower endos-
copy prior to capsule endoscopy and 12 had abnormali-
ties that were already known prior to capsule endoscopy. 
The most common type of missed lesions were vascular 
lesions (n  = 47). Non-small-bowel abnormalities were 
located in the stomach (n  = 15), proximal small bowel 
(n  = 22), terminal ileum (n  = 21), colon (n  = 19) or at 
other or multiple locations (n  = 8). Ten patients with 
abnormal findings in the terminal ileum had not under-
gone examination of the ileum during colonoscopy. 
CONCLUSION: A significant proportion of patients 
undergoing small bowel capsule endoscopy had lesions 
within reach of conventional endoscopes, indicating 
that capsule endoscopy was unnecessarily performed.
© 2014 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: Capsule endoscopy (CE) is a technique to de-
tect small bowel pathology which sometimes reveals 
non-small bowel abnormalities (NSBAs). There are no 
data on the incidence of NSBAs in capsule endoscopy. 
In this study, 595 capsule endoscopy procedures were 
included. Abnormalities were found in 306 (51.4%) of 
cases. Of these 306 patients, 85 (27.7%) had abnor-
malities within reach of conventional endoscopes. The 
fact that a significant proportion of patients referred for 
small bowel CE had lesions within the reach of conven-
tional endoscopes indicates that CE was unnecessarily 
performed and emphasizes the importance of critical 
selection of patients for capsule endoscopy.
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INTRODUCTION
Small bowel capsule endoscopy (CE) has become an es-
tablished method for visualization of  the small bowel[1-4]. 
One of  the main indications for CE is obscure gastro-
intestinal bleeding. Obscure gastrointestinal bleeding is 
defined as bleeding from the digestive tract that persists 
or recurs without an obvious etiology after a normal 
esophagogastroduodenoscopy and colonoscopy[1]. It can 
be categorized into overt and occult obscure gastroin-
testinal bleeding based on the presence or absence of  
clinically evident bleeding. Approximately 5% of  patients 
presenting with gastrointestinal bleeding have no identi-
fied source on upper endoscopy and colonoscopy[1]. The 
cause of  obscure gastrointestinal bleeding is usually a le-
sion located in the small bowel, but also includes lesions 
that were overlooked during conventional endoscopy, 
either because of  intermittent bleeding or truly missed 
lesions. Another important indication for small bowel 
capsule endoscopy is suspected Crohn’s disease (CD). 
Usually, prior to the procedure, colonoscopy is being per-
formed, preferably including endoscopic inspection of  
the terminal ileum. So, most patients referred for small 
bowel capsule endoscopy have undergone conventional 
endoscopies prior to the procedure.
Another method to investigate the small bowel is 
single- or double balloon enteroscopy[5,6]. As in capsule 
endoscopy, most patients referred for balloon enteros-
copy have undergone conventional upper and lower en-
doscopy before the procedure is conducted[7]. It is known 
that balloon enteroscopy reveals abnormalities within 
reach of  conventional endoscopes in up to 15%-24% 
of  patients[8,9]. These findings are generally referred to 
as non-small-bowel abnormalities (NSBAs)[8-10]. There 
are no firm data on the incidence of  NSBAs in capsule 
endoscopy. The aim of  this study was therefore to deter-
mine the incidence of  findings within reach of  conven-
tional endoscopes in patients referred for CE.
MATERIALS AND METHODS
Patients and techniques
Data from all consecutive CE studies performed at 
the University Medical Centre Groningen, the Nether-
lands, between September 2003 and January 2009 were 
prospectively collected. Our hospital is a tertiary-care 
centre with a referral base drawing from the northern 
part of  the Netherlands. Data were collected on patient 
demographics, indications for the procedure, procedural 
data, including gastric and small bowel transit time, and 
findings of  the procedure. CE was considered complete 
when the cecum was reached within recording time. NS-
BAs were defined as all abnormal findings found at cap-
sule endoscopy located in the stomach, proximal small 
bowel, terminal ileum, and colon. Data were retrieved 
with respect to the extent and number of  endoscopies 
performed prior to CE and whether or not ileoscopy was 
performed during colonoscopy. In case of  missing data 
from externally referred patients, the referring hospital 
was contacted or visited.
CE procedure
All patients received the same bowel preparation during 
the study period. The patients were given standardized 
instructions before the procedure, and informed con-
sent was obtained. The patients were asked to stop iron 
supplements seven days before CE and to use a low-fiber 
diet 3 d before CE. The patients started a fasting period 
at midnight before the procedure. Bowel preparation 
consisted of  four liters of  polyethylene glycol (PEG), 
given as 3 L the evening before the procedure and 1 L 
in the morning. The capsule (Pillcam; Given Imaging 
Ltd, Yoqneam, Israel) was swallowed in the morning. 
The patients were allowed to drink fluids after 3 h and to 
consume a light meal after 5 h. Before capsule ingestion, 
100 mL of  antifoam and a prokinetic agent was given, 
10 mg of  domperidone (before July 1st 2008, n = 641) 
or 250 mg of  erythromycin (after July 1st 2008, n = 69). 
All CE procedures were reviewed by two gastroenterolo-
gists, experienced with capsule endoscopy (Weersma R 
and Koornstra JJ). Controversial findings were discussed, 
and consensus was reached upon the final diagnosis. The 
most relevant findings obtained from CE were docu-
mented and categorized according to standard terminol-
ogy (10) as angiectasia(s); ulcer(s); active bleeding of  
unknown origin; erosion(s); polyp(s)/tumor(s); incidental 
abnormality of  esophagus, stomach, or colon; no abnor-
mality; or unable to make a diagnosis. 
Statistical analysis
P values below 0.05 were considered significant. SPSS 
14.0 for Windows software (SPSS Inc., Chicago, IL, Unit-
ed States) were used for statistical analyses.
RESULTS
During the study period, 710 capsule endoscopy proce-
dures were performed in 674 patients. 389 patients were 
female (54.8%) and the average age was 55 years (range 
9-93, SD 18). Most of  the patients were referred for cap-
sule endoscopy for analysis of  obscure-occult gastroin-
testinal bleeding (n = 392, 55.2%), obscure-overt gastro-
intestinal bleeding (n = 87, 12.3%) or suspected CD (n = 
116, 16.3%). Given the aim of  our study, further analysis 
was limited to these 595 patients. 331 patients (55.6%) 
were referred by physicians from other hospitals.
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Previous examinations and capsule endoscopy findings
Patients had undergone a mean number of  1.1 (range 0-5) 
esophagogastroduodenoscopy procedures and 1.1 (range 
0-9) colonoscopy procedures prior to capsule endoscopy. 
During colonoscopy, the terminal ileum had been intu-
bated in 41.2% of  patients. In addition to conventional 
endoscopy procedures, 20.6% of  patients had undergone 
a small-bowel-follow-through examination and 9.9% of  
patients had undergone a push-enteroscopy prior to CE. 
The coecum was reached within recording time in 487 
(81.8%) of  capsule endoscopy procedures. Findings of  
capsule endoscopy are summarized in Table 1. In 291 CE 
procedures, abnormalities were found. The most com-
mon abnormal findings were angiodysplasias (n = 115, 
19.3%) and erosion(s) (n = 68, 11.4%). 
Non-small-bowel abnormalities
In 85 patients (14.3%), abnormalities were found within 
reach of  conventional endoscopes, summarized in Table 
2. In most patients (n = 63, 10.6%), this concerned un-
known abnormalities in patients that had undergone both 
gastroduodenoscopy and colonoscopy prior to CE. In 10 
patients (1.7%), NSBAs were found while patients had 
not undergone esophagogastroduodenoscopy and ileoco-
lonoscopy prior to CE and in 12 patients (2.0%), NSBAs 
were found that were already known prior to capsule 
endoscopy. NSBAs were located in: stomach (n = 15), 
duodenum (n = 12), proximal jejunum (n = 10), terminal 
ileum (n = 21), colon (n = 19) or at other or at multiple 
locations (n = 8). The types of  lesions encountered are 
summarized in Table 2: angiodysplasias (n = 32, 37.6%), 
erosion(s) (n = 16, 18.8%), active bleeding (n = 15, 
17.6%) and inflammatory lesions (n = 12, 14.1%). 59 of  
85 patients (69.4%) with NSBAs concerned patients re-
ferred from other hospitals. CD was suspected in 116 of  
595 patients (19%). Abnormalities in the terminal ileum 
were seen in 39 patients (33.6%). In only 12 of  these 39 
patients (30.8%), the terminal ileum had been inspected 
during previous colonoscopy.
DISCUSSION
In this study, we found that in patients referred for cap-
sule endoscopy it is not uncommon to find non-small-
bowel abnormalities, so findings within the reach of  
conventional esophagogastroduodenoscopy or ileocolo-
noscopy related to the indication for the procedure. We 
included only patients who were referred for obscure or 
occult bleeding and for suspected CD, because patients 
with other indications for CE, such as suspicion of  carci-
noid do not generally undergo both esophagogastroduo-
denoscopy and ileocolonoscopy prior to CE.
Non-small-bowel abnormalities within reach of  con-
ventional endoscopes were found in 14.3% of  all proce-
dures and could be present in the upper and lower gas-
trointestinal tract. Vascular lesions were the abnormalities 
most often found. It must be noted that two-thirds of  
these patients had undergone conventional upper and 
lower tract endoscopy with ileoscopy before the capsule 
endoscopy procedure. One could assume that these le-
sions were truly overlooked at previous examinations. Al-
ternatively, it may concern intermittently bleeding lesions.
Data on the incidence of  non small bowel abnormali-
ties in CE are limited. To the best of  our knowledge, only 
two studies investigated this subject. In a series of  140 
capsule endoscopy procedures for obscure gastrointes-
tinal bleeding, NSBA were found in 9 patients (6.4%)[7]. 
In another series of  317 CE procedures, NSBA were 
found in 11 patients (3.5%), in which the investigators 
differentiated between referred patients (6.3%) and non-
referred patients (1.2%). In this study, the terminal ileum 
was not defined as a location for NSBA[11]. The incidence 
of  NSBA has also been investigated in double balloon 
endoscopy (DBE) procedures[8,9]. In these studies, NS-
BAs were found in 14.3 % and 24 % of  cases respec-
tively. One could assume that the sensitivity of  DBE is 
slightly higher for small bowel abnormalities than that of  
CE, although most studies indicate a similar diagnostic 
yield[5,12-21]. 
In this study we investigated the incidence of  NSBAs 
in relation to prior examinations. A limitation of  our 
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Table 1  Findings of capsule endoscopy procedures (595 
procedures)  n  (%)
Procedures n  = 595 
 No abnormalities 289 (48.6)
 Angiodysplasia(s) 115 (19.3)
 Erosion(s)   68 (11.4)
 Ulcer(s) 34 (5.7)
 Polyp/tumor 31 (5.2)
 Active bleeding 28 (4.7)
 Other 30 (5.0)




NSBA   85 (14.3)
   NSBA known before CE 12 (2.0)
   NSBA unknown before CE   63 (10.6)
   sNSBA with incomplete previous examinations 10 (1.7)
Location of NSBA 
   Stomach   15 (17.6)
   Duodenum   12 (14.1)
   Proximal jejunum   10 (11.8)
   Terminal ileum   21 (24.7)
   Colon   19 (22.4)
   Other   8 (9.4)
Type of NSBA
   Angiodysplasia(s)   32 (37.6)
   Erosion(s)   16 (18.8)
   Active bleeding   15 (17.6)
   Inflammation   12 (14.1)
   Polyp/tumor   6 (7.1)
   Other   4 (4.7)
NSBA: Non-small bowel abnormalitie; CE: Capsule endoscopy.
Hoedemaker RA et al . Non-small bowel capsule endoscopy findings
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Capsule endoscopy (CE) is a very sensitive diagnostic technique to detect 
small bowel pathology. Another method to investigate the small bowel is 
single- or double-balloon enteroscopy. As in capsule endoscopy, most patients 
referred for balloon enteroscopy have undergone conventional upper and lower 
endoscopy before the procedure is conducted. It is known that balloon enter-
oscopy reveals abnormalities within reach of conventional endoscopes in up 
to 15%-24% of patients. These findings are generally referred to as non-small-
bowel abnormalities. There are no robust data on the incidence of NSBAs in 
capsule endoscopy. This was the subject of this study.
Research frontiers
This the first study that investigated the incidence of non-small-bowel abnor-
malities in small bowel capsule endoscopy.
Innovations and breakthroughs
In this study, 595 capsule endoscopy procedures were included. Patients were 
referred for obscure gastrointestinal bleeding or for suspected Crohn’s disease. 
Abnormalities were found in 306 (51.4%) of cases. Of these 306 patients, 85 
(27.7%) had abnormalities within reach of conventional endoscopes; 63 had 
abnormalities apparently overlooked at previous conventional endoscopies, 
10 patients had not undergone upper and lower endoscopy prior to capsule 
endoscopy and 12 had abnormalities that were already known prior to capsule 
endoscopy. The most common type of missed lesions were vascular lesions 
(n = 47). Non-small-bowel abnormalities were located in the stomach (n = 15), 
proximal small bowel (n = 22), terminal ileum (n = 21), colon (n = 19) or at other 
or multiple locations (n = 8). Ten patients with abnormal findings in the terminal 
ileum had not undergone examination of the ileum during colonoscopy. 
Applications
What does this mean for clinical practice? The fact that a significant proportion 
of patients referred for small bowel CE had lesions within the reach of con-
ventional endoscopes indicates that CE was unnecessarily performed. Before 
planning a CE procedure, careful upper and lower endoscopies should be 
performed including ileoscopy. Repeating these investigations, if not properly 
performed before CE, should be considered. 
Peer review
This work emphasizes the importance of critical selection of patients for capsule 
endoscopy.
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